AJANTPHARM Intraday Analysis...

AJANTPHARM Share Price

Open 1477.00 Change Price %
High 1483.80 1 Day -2.25 -0.15
Low 1449.55 1 Week -28.75 -1.93
Close 1464.20 1 Month -69.90 -4.56
Volume 69296 1 Year -157.75 -9.73
52 Week High 2125.00
52 Week Low 1401.65
AJANTPHARM Important Levels
Resistance 2 1495.95
Resistance 1 1482.87
Pivot 1465.85
Support 1 1445.53
Support 2 1432.45
NSE INDIA Most Active Stocks
JPASSOCIAT 26.60 15.40%
GVKPIL 10.00 19.76%
SINTEX 37.35 -1.32%
GMRINFRA 18.00 1.12%
SUZLON 19.15 3.51%
UNITECH 8.45 -1.17%
IDEA 91.95 -3.26%
IFCI 27.55 4.95%
RENUKA 19.40 17.22%
STRTECH 222.80 7.53%
More..
NSE INDIA Top Gainers Stocks
SPCENET 0.20 33.33%
TIPSINDLTD 79.20 20.00%
GVKPIL 10.00 19.76%
RENUKA 19.40 17.22%
TARAJEWELS 32.05 16.76%
NAKODA 0.35 16.67%
ARCOTECH 98.20 16.08%
SIGNET 10.65 15.76%
JPASSOCIAT 26.60 15.40%
LYKALABS 61.25 15.35%
More..
NSE INDIA Top Losers Stocks
LCCINFOTEC 0.20 -20.00%
SERVALL 2.55 -10.53%
MVL 0.50 -9.09%
MVL 0.50 -9.09%
ANKITMETAL 1.30 -7.14%
JVLAGRO 25.05 -7.05%
DISHTV 78.10 -6.02%
NUCLEUS 289.55 -5.90%
COUNCODOS 4.00 -5.88%
RSSOFTWARE 78.95 -5.56%
More..

Ajanta Pharma Limited (NSE: AJANTPHARM)

AJANTPHARM Technical Analysis 5
As on 21st Jul 2017 AJANTPHARM Share Price closed @ 1464.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1769.14 & Strong Sell for SHORT-TERM with Stoploss of 1562.63 we also expect STOCK to react on Following IMPORTANT LEVELS.
AJANTPHARM Target for July
1st Target up-side 1612.26
2nd Target up-side 1659.48
3rd Target up-side 1706.69
1st Target down-side 1477.54
2nd Target down-side 1430.32
3rd Target down-side 1383.11
AJANTPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 34.76 Sideways
MFI (14) MFI is 43.21 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 1597.73
10 Day Avg Volume Traded -44.88 % Less then 10 Day Average Volume
AJANTPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.ajantapharma.com
AJANTPHARM Address
AJANTPHARM
98, Ajanta House
Charkop
Mumbai, 400067
India
Phone: 91 22 6606 1000
Fax: 91 22 6606 1200
AJANTPHARM Latest News
Ajanta Pharma Ltd Fixes Record Date for Stock Split   Equity Bulls   - 12th Mar 15
Bullish on Atul Auto, Ajanta Pharma and PVR: Pankaj Pandey, ICICIdirect.com   Economic Times   - 18th Feb 15
Ajanta Pharma board approves stock split   Hindu Business Line   - 28th Jan 15
Ajanta Pharma shares soar over 12 per cent on healthy earnings   Economic Times   - 28th Jan 15
Ajanta Pharma Q3 net profit rises 38% to Rs 85 crore   Economic Times   - 28th Jan 15
Ajanta Pharma Ltd to announce Q3 results on Jan 28, 2015   Equity Bulls   - 17th Jan 15
Ajanta Pharma Announces the Launch of Risperidone Tablets   PR Newswire (press release)   - 09th May 14
Ajanta Pharma records robust growth in income, net profit   Hindu Business Line   - 27th Jan 14
Ajanta Pharma Ltd. Succeeded In Revoking Two Composition Patents Of ...   Mondaq News Alerts (registration)   - 25th Sep 13
Ajanta Pharma fixes record date for bonus Issue   Moneycontrol.com   - 06th Sep 13
Interactive Technical Analysis Chart Ajanta Pharma Limited ( AJANTPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Ajanta Pharma Limited
AJANTPHARM Business Profile
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets and it was established in 1973 and headquartered in Mumbai-India.The company focuses on commercializing unique generic products and synergistic combination products in the therapeutic areas of anti-malarial, Cardiovascular, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology. The company has reported a standalone sales of Rs 279.83 crore and a Net Profit of Rs 55.81 crore for the quarter ended September 2013. The Registered office is at 98, Ajanta House, Charkop, Kandivili (West), Mumbai - 400 067.